Of note, APC treatment of LPS-challenged EPCR δ/δ , but not of PAR1 −/− , mice elicited a highly significant 10- and 7-fold augmentation of IL-6 and monocyte chemoattractant protein 1 levels, respectively (Table S3).
← all excerpts
Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C.
1
—
—